Subcutaneous (SC) - limited absorption

Subcutaneous fluid administration represents one of the most commonly utilized fluid therapy techniques in small mammal medicine, providing a practical and relatively non-invasive method for delivering fluids to patients with mild to moderate hydration deficits. This technique involves the injection of sterile crystalloid solutions into the subcutaneous space, the layer of loose connective tissue between the skin and underlying muscle, where the fluids form a temporary pocket that is gradually absorbed into the systemic circulation over several hours. In small mammal practice, subcutaneous fluids serve as a cornerstone of outpatient supportive care and chronic disease management, offering a route that can be safely performed by trained owners in the home environment.

The development of subcutaneous fluid therapy in small mammal medicine has paralleled its widespread adoption in feline practice, where the technique has been a mainstay of chronic kidney disease management for decades. Small mammals, like cats, tolerate subcutaneous fluid administration well, and the technique has proven invaluable for managing chronic conditions requiring ongoing hydration support. The relative ease of the procedure, combined with its safety profile when performed correctly, has made it one of the most frequently taught owner-administered treatments in exotic animal practice. Modern approaches emphasize proper technique, appropriate patient selection, and recognition of the limitations of this route compared to more direct vascular access methods.

Subcutaneous fluid administration is typically performed using isotonic crystalloid solutions such as lactated Ringer's solution or normal saline, delivered through small-gauge needles or butterfly catheters into the loose skin of the scruff or lateral body wall. The fluid creates a visible swelling at the injection site that gradually diminishes as absorption occurs over the following hours. In small mammals, absorption rates are generally adequate for maintenance hydration needs and correction of mild deficits, though significant limitations exist for patients requiring rapid fluid resuscitation or those with compromised peripheral perfusion.

Understanding the appropriate applications and limitations of subcutaneous fluid administration is essential for optimal patient care. While this route offers significant advantages for certain clinical scenarios, including ease of administration, low complication rates, and suitability for home use, it cannot replace more direct fluid delivery routes when rapid volume replacement is needed. Patients with severe dehydration, cardiovascular compromise, or shock require intravenous or intraosseous fluid access for effective resuscitation. The exotic veterinarian will determine when subcutaneous fluids are appropriate and when alternative routes are necessary based on comprehensive patient assessment.

Subcutaneous fluid administration serves multiple important purposes in small mammal medicine, with applications ranging from chronic disease management to acute supportive care in appropriately selected patients. The primary indication is maintenance hydration support for patients who cannot maintain adequate fluid intake through voluntary drinking or who have ongoing fluid losses that exceed their ability to compensate. This technique is particularly valuable for outpatient management of chronic conditions where regular fluid supplementation can significantly improve quality of life and disease outcomes.

Chronic kidney disease represents one of the most common indications for long-term subcutaneous fluid therapy in small mammals, particularly in ferrets where this condition is relatively prevalent. Affected patients often experience chronic dehydration due to impaired urine concentrating ability, and regular subcutaneous fluid administration helps maintain hydration status, supports renal perfusion, and improves overall wellbeing. Similar to feline CKD management, ferrets with chronic kidney disease may receive subcutaneous fluids multiple times weekly for the remainder of their lives, with this supportive care significantly contributing to their quality and quantity of life.

Mild to moderate dehydration from various causes can be effectively addressed through subcutaneous fluid administration in hemodynamically stable patients. Small mammals with reduced water intake due to dental disease, mild gastrointestinal upset, or post-surgical recovery often benefit from subcutaneous fluid supplementation. Patients with increased fluid losses from diarrhea, excessive urination, or environmental factors may similarly benefit from subcutaneous fluid support. The gradual absorption of subcutaneously administered fluids provides sustained hydration over several hours, making this route appropriate for conditions where continuous fluid support is beneficial but emergency resuscitation is not required.

Outpatient management between veterinary visits frequently incorporates subcutaneous fluid therapy for stable small mammal patients. Owners can be trained to safely administer subcutaneous fluids at home, allowing continued supportive care without the stress and expense of repeated hospitalization. This approach is particularly valuable for chronic conditions requiring ongoing management and for post-surgical recovery when patients are stable enough for outpatient care but still benefit from supplemental hydration. Regular fluid administration at home can prevent minor dehydration episodes from progressing to more serious illness requiring emergency intervention.

Perioperative support in low-risk procedures may utilize subcutaneous fluids as part of overall fluid management in some small mammal patients. While intravenous fluids remain the standard for significant surgical procedures, minor procedures in healthy patients may be supported with subcutaneous fluid administration when IV access is not established. Pre-operative subcutaneous fluids can help ensure adequate hydration status before anesthesia, while post-operative administration supports recovery in patients discharged for home care. The exotic veterinarian determines appropriate perioperative fluid protocols based on procedure type, patient status, and expected recovery course.

Subcutaneous fluid administration in small mammals requires attention to technique, fluid selection, and volume calculations tailored to each patient's species, size, and clinical condition. All specific fluid volumes and frequencies should be determined by an experienced exotic animal veterinarian based on comprehensive patient assessment. This section provides general guidance on administration principles while emphasizing that individualized protocols are essential for optimal patient outcomes.

Injection site selection for subcutaneous fluid administration depends on species, individual patient anatomy, and the volume to be administered. The loose skin over the shoulders and scruff area provides the most commonly utilized site in most small mammals, as this region has ample subcutaneous space and is relatively easy to access. In rabbits, the skin along the lateral body wall between the shoulders and hips provides an alternative site with good subcutaneous capacity. Guinea pigs and chinchillas similarly tolerate scruff or lateral body wall administration. The chosen site should be rotated between administrations when repeated treatments are required to prevent local tissue irritation or damage.

Needle selection for subcutaneous fluid administration balances comfort with flow rate considerations. Smaller gauge needles, such as 23 to 25 gauge, minimize patient discomfort but may require longer administration times for larger volumes. Butterfly needles or winged infusion sets are preferred by many practitioners for their stability during administration and reduced risk of needle displacement as the patient moves. The needle length should be appropriate for the patient size, with shorter needles adequate for most small mammal species. Proper needle insertion involves lifting a tent of skin, inserting the needle at an angle into the subcutaneous space, and confirming proper placement before beginning fluid administration.

Fluid selection for subcutaneous administration is generally limited to isotonic crystalloid solutions. Lactated Ringer's solution is most commonly used due to its balanced electrolyte composition and physiological compatibility. Normal saline provides an acceptable alternative, though its higher chloride content may be less ideal for long-term use. Hypotonic and hypertonic solutions are generally not appropriate for subcutaneous administration due to the potential for local tissue irritation and unpredictable absorption. Solutions containing dextrose are typically avoided for subcutaneous use as they may cause local irritation and provide a medium for bacterial growth if contamination occurs. The exotic veterinarian will select appropriate fluid types based on patient needs.

Volume calculations for subcutaneous fluid administration in small mammals depend on patient size, hydration deficit, and tolerance for subcutaneous fluid pockets. General guidelines suggest that most small mammals can tolerate 20 to 30 milliliters per kilogram of body weight per injection site, though this varies considerably by species and individual. Administering excessive volumes at a single site can cause discomfort, prolonged absorption times, and potentially tissue complications. When larger total volumes are needed, dividing the dose between multiple injection sites is preferred over overloading a single site. The exotic veterinarian will provide specific volume recommendations based on patient assessment.

Administration technique involves slow, controlled delivery of fluids to maximize patient comfort and facilitate proper distribution within the subcutaneous space. Warming fluids to body temperature before administration improves comfort and may enhance absorption. The fluid pocket should be observed during administration to ensure proper subcutaneous placement rather than intradermal or intramuscular injection. Following administration, gentle massage of the fluid pocket can help distribute fluids within the subcutaneous space and improve comfort. Patients should be monitored following administration for any signs of complications and allowed to rest in a comfortable environment during the absorption period.

Subcutaneous fluid administration in small mammals is generally well-tolerated with a favorable safety profile when performed correctly, though potential complications can occur that practitioners and owners should understand. Awareness of these possible adverse effects enables appropriate monitoring and early intervention when problems develop.

Local reactions at the injection site represent the most commonly observed adverse effects of subcutaneous fluid administration. Transient swelling at the injection site is expected and normal following subcutaneous fluid administration, as the fluid pocket must be absorbed over several hours. However, persistent or excessive swelling may indicate slow absorption, fluid leakage from the injection site, or accumulation of serial administrations. Bruising at injection sites can occur, particularly in patients receiving anticoagulant medications or those with coagulation abnormalities. Mild discomfort during injection is common but should be minimized through proper technique including use of appropriate needle size, warming of fluids, and slow administration rates.

Infection at injection sites, while uncommon with proper aseptic technique, can occur and may range from localized cellulitis to abscess formation. Signs of injection site infection include persistent swelling, warmth, redness, pain, and potentially purulent discharge. Small mammals are generally resistant to injection site infections when clean technique is used, but immunocompromised patients or those with underlying skin conditions may be at elevated risk. Prevention through appropriate skin preparation, use of sterile equipment, and proper injection technique is essential. Any suspected injection site infection requires veterinary evaluation and appropriate treatment.

Fluid overload is possible if excessive volumes are administered, particularly in patients with underlying cardiac or renal disease that impairs their ability to handle fluid loads. Signs of fluid overload include respiratory distress, peripheral edema, and weight gain beyond what would be expected from rehydration alone. Small mammals have relatively small total blood volumes and can develop fluid overload from seemingly modest subcutaneous fluid volumes if their cardiovascular or renal function is compromised. Patients receiving chronic subcutaneous fluid therapy should be monitored regularly for signs of fluid accumulation, and volumes adjusted based on clinical response and ongoing needs.

Incomplete or delayed absorption represents a significant limitation of subcutaneous fluid therapy that can result in persistent fluid accumulation and inadequate systemic hydration. Patients with peripheral vasoconstriction from shock, severe dehydration, or hypothermia have markedly reduced subcutaneous absorption, making this route ineffective for their fluid needs. Cold fluids absorb more slowly than warmed fluids and may contribute to patient hypothermia. Repeated injections at the same site can cause local tissue changes that impair absorption. Recognition that subcutaneous fluids are not being absorbed appropriately should prompt reassessment of the patient's cardiovascular status and consideration of alternative fluid routes.

Rare complications include subcutaneous emphysema from inadvertent air injection, nerve damage from improper needle placement, and sterile abscess formation. These complications are uncommon when proper technique is employed but should be recognized if they occur. Contact your exotic veterinarian if you observe unexpected reactions, persistent swelling, signs of infection, or if your pet appears uncomfortable or unwell following subcutaneous fluid administration.

Subcutaneous fluid administration is contraindicated or limited in effectiveness under certain circumstances that must be recognized to ensure appropriate patient care. Understanding these contraindications helps direct therapy toward more effective routes when subcutaneous administration would be inadequate or harmful.

Severe dehydration requiring rapid fluid replacement represents a primary contraindication to exclusive subcutaneous fluid therapy. The absorption rate of subcutaneously administered fluids is insufficient to address acute, severe fluid deficits or to resuscitate patients in hypovolemic shock. Patients with severely reduced skin turgor, sunken eyes, markedly prolonged capillary refill time, or cardiovascular instability require intravenous or intraosseous fluid access for effective resuscitation. Attempting to manage severely dehydrated patients with subcutaneous fluids alone may result in inadequate treatment and clinical deterioration. While subcutaneous fluids may play a role in ongoing management after initial stabilization, they should not replace appropriate parenteral therapy during the acute phase of severe dehydration.

Peripheral vasoconstriction from any cause markedly impairs subcutaneous fluid absorption, making this route ineffective in patients with compromised peripheral perfusion. Hypothermia, shock, severe pain, and certain medications can all cause peripheral vasoconstriction that prevents adequate absorption of subcutaneously administered fluids. In these patients, the fluid pocket remains in the subcutaneous space without reaching the systemic circulation, providing no therapeutic benefit while potentially complicating assessment of the patient's true fluid status. Recognition of impaired peripheral perfusion should prompt use of alternative fluid routes that bypass the absorption limitations.

Local skin conditions at potential injection sites may contraindicate subcutaneous fluid administration at those locations. Dermatitis, wounds, infections, or other skin abnormalities at the scruff or typical injection sites should be avoided to prevent contamination of injected fluids and worsening of skin conditions. In patients with widespread skin disease, finding appropriate injection sites may be challenging. Burns or significant tissue trauma affecting typical subcutaneous injection areas similarly contraindicate use of those sites. Alternative sites should be sought when primary sites are compromised, or alternative fluid routes may be necessary if no suitable subcutaneous sites are available.

Certain patient conditions require caution with subcutaneous fluid therapy even when the route may be technically appropriate. Patients with congestive heart failure may not tolerate fluid loads delivered even gradually through the subcutaneous route. Severely hypoproteinemic patients may experience third-spacing of administered fluids rather than effective intravascular volume expansion. Patients with coagulation abnormalities may develop significant bruising or hematoma formation at injection sites. These conditions do not absolutely contraindicate subcutaneous fluids but require careful consideration of risks and benefits by the exotic veterinarian, with appropriate monitoring for complications.

Subcutaneous fluid administration serves primarily as a hydration delivery method rather than a medication, meaning that drug interactions relate mainly to other substances administered through this route or to the effects of hydration status on concurrent medications. Understanding these interactions helps ensure that subcutaneous fluid therapy supports overall treatment goals in small mammal patients.

Medication administration via the subcutaneous route alongside fluids requires consideration of compatibility and absorption characteristics. While subcutaneous fluids themselves are generally isotonic crystalloid solutions without direct drug interactions, some medications are administered via the subcutaneous route and may be given during the same handling session as fluid therapy. Injectable medications with different pH, osmolarity, or other characteristics than the fluid being administered should generally be given at separate sites to avoid local compatibility issues. The exotic veterinarian will provide guidance on appropriate timing and site selection when multiple subcutaneous substances must be administered.

Hydration status affects the pharmacokinetics of many medications, making subcutaneous fluid therapy relevant to overall drug management in small mammal patients. Dehydrated patients may have altered drug distribution, metabolism, and elimination compared to well-hydrated individuals. Maintaining adequate hydration through subcutaneous fluid therapy can help ensure more predictable drug behavior for medications being administered through any route. Conversely, fluid therapy may increase drug elimination for renally excreted medications, potentially affecting dosing requirements. The exotic veterinarian considers hydration status when establishing medication protocols and may adjust doses based on fluid therapy status.

Diuretic medications interact with fluid therapy in predictable ways that should be managed to avoid dehydration or fluid overload. Patients receiving diuretics for cardiac disease or other conditions may require increased fluid supplementation to compensate for enhanced urinary losses, though this must be carefully balanced against the underlying indication for diuretic therapy. The exotic veterinarian will determine appropriate fluid volumes for patients receiving diuretics based on their overall clinical picture, balancing the need to prevent dehydration against the risk of exacerbating fluid-related conditions.

Nephrotoxic medications require particular attention to hydration status to minimize renal injury. Aminoglycoside antibiotics, certain antifungal agents, and some chemotherapy drugs have enhanced nephrotoxic potential in dehydrated patients. Subcutaneous fluid therapy may be employed before, during, and after administration of nephrotoxic medications to ensure adequate renal perfusion and promote drug elimination. This protective hydration can reduce the risk of drug-induced kidney damage while allowing necessary medications to be administered more safely. The exotic veterinarian will establish appropriate fluid protocols when nephrotoxic medications are part of the treatment plan.

Subcutaneous fluid administration in small mammals requires attention to technique, patient selection, and monitoring to ensure safety and therapeutic efficacy. The following precautions and warnings are essential for both veterinary professionals and owners performing subcutaneous fluid therapy in exotic small mammal patients.

Proper training before initiating home subcutaneous fluid administration is essential for owner safety and patient welfare. While subcutaneous fluid therapy is generally safe, incorrect technique can result in complications including needle stick injuries to owners, improper fluid delivery, injection site infections, and patient distress. Initial training should be provided by veterinary staff with hands-on demonstration and supervised practice before owners attempt independent administration. Written instructions and video resources can supplement in-person training but should not replace direct instruction. Owners should feel confident in their ability to safely handle their pet, properly load and prime administration sets, and perform the injection before taking responsibility for home therapy.

Recognition of limited absorption is crucial for appropriate patient selection and monitoring. Subcutaneous fluids depend on adequate peripheral perfusion for absorption into the systemic circulation. Patients with cool extremities, pale mucous membranes, prolonged capillary refill time, or other signs of peripheral vasoconstriction will not absorb subcutaneous fluids effectively. Monitoring for persistent fluid pockets that do not resolve within expected timeframes helps identify absorption problems. If fluid pockets from previous administrations remain when the next dose is due, the exotic veterinarian should be consulted about adjusting the protocol or pursuing alternative fluid routes.

Temperature management during subcutaneous fluid administration helps ensure patient comfort and optimize absorption. Fluids should be warmed to body temperature before administration, as cold fluids cause discomfort and may be absorbed more slowly. Small mammals are particularly susceptible to hypothermia, and administration of room-temperature fluids can contribute to body heat loss. Commercial fluid warmers, warm water baths, or simply rolling the fluid bag between hands can achieve appropriate warming. Fluids should not be overheated, as excessively warm fluids can cause thermal injury to tissues.

Aseptic technique during subcutaneous fluid administration prevents infection at injection sites and maintains fluid sterility. Hands should be washed before handling supplies, and injection sites should be assessed for any existing abnormalities before needle insertion. While extensive skin preparation is not typically performed for routine subcutaneous injections in small mammals, visibly soiled areas should be cleaned. Needles should not be reused between patients and should generally be changed between multiple injections even in the same patient to maintain sharpness and sterility. Fluid bags punctured for administration should be dated and used within appropriate timeframes, typically 24 to 48 hours, or discarded to prevent bacterial contamination.

Ongoing monitoring of patients receiving chronic subcutaneous fluid therapy ensures appropriate response to treatment and early identification of complications. Body weight should be tracked regularly to assess hydration status and detect fluid accumulation. Overall demeanor, appetite, and activity level provide subjective measures of treatment response. Injection sites should be examined for persistent swelling, infection, or tissue changes that might indicate need for site rotation or other protocol adjustments. Regular veterinary rechecks allow for assessment of underlying disease progression and adjustment of fluid therapy protocols as patient needs evolve.

The fluids and supplies used for subcutaneous administration in small mammals require appropriate storage and handling to maintain sterility, efficacy, and safety. Proper organization and maintenance of fluid therapy supplies ensures availability when needed while preventing complications associated with contaminated or degraded materials.

Intravenous fluid bags used for subcutaneous administration should be stored at room temperature and protected from freezing, excessive heat, and direct sunlight. Crystalloid solutions including lactated Ringer's solution and normal saline typically have shelf lives of one to two years when stored properly in intact packaging. Fluids should be inspected before each use for particulate matter, cloudiness, or discoloration that might indicate contamination or degradation. The outer packaging should be checked for damage that might have compromised sterility. Expired fluids should be discarded and replaced rather than administered to patients.

Once a fluid bag is punctured for administration, contamination risk increases and the bag should be used within limited timeframes. Most veterinary protocols recommend using punctured fluid bags within 24 to 48 hours when stored appropriately between uses. The date and time of first puncture should be marked on the bag for reference. Between uses, the spike port should be protected from contamination, and the bag should be stored in a clean environment. Fluids that have been at room temperature for extended periods during multiple administration sessions may be at higher contamination risk than those maintained under refrigeration, though cold fluids must be warmed before administration.

Administration sets including tubing, drip chambers, and needles require appropriate storage and handling. Unopened administration sets should be stored in their sterile packaging until needed. Once opened and used, most administration sets are disposed of rather than reused, though some protocols allow limited reuse with the same patient over short timeframes. Needles should never be reused between patients and are typically disposed of after each administration session. Sharps must be disposed of in appropriate puncture-resistant containers to prevent needlestick injuries. Owners performing home fluid therapy should be provided with sharps containers and instructions for proper disposal.

Home storage considerations for owners administering subcutaneous fluids include maintaining supplies in a clean, organized location away from household contaminants, children, and pets. Fluid bags, administration sets, and needles should be kept together with any other supplies needed for administration. Adequate supplies should be maintained to prevent running out between veterinary visits, with owners understanding how to obtain refills. Temperature extremes in home storage locations, such as garages or vehicles, should be avoided. The veterinary team should provide clear guidance on storage requirements and expected supply needs based on the prescribed fluid therapy protocol.

Subcutaneous fluid administration techniques and considerations vary among small mammal species based on anatomical differences, tolerance for handling, and specific disease conditions commonly encountered in each species. Understanding species-specific factors helps practitioners and owners optimize subcutaneous fluid therapy for individual patients.

Rabbits tolerate subcutaneous fluid administration well and commonly receive this therapy for various conditions including GI stasis, dental disease, and post-surgical support. The loose skin over the shoulders and along the lateral body wall provides ample subcutaneous space for fluid administration. Most adult rabbits can tolerate 50 to 100 milliliters per site depending on body size, though specific volumes should be determined by the exotic veterinarian. Rabbits may be more accepting of the procedure when wrapped in a towel for gentle restraint, with the injection site exposed. The generally calm temperament of well-handled rabbits makes this species well-suited for owner-administered home fluid therapy once appropriate training has been provided.

Guinea pigs and chinchillas require proportionally smaller fluid volumes based on their body size but otherwise tolerate subcutaneous fluid administration similarly to rabbits. The scruff area provides the most accessible injection site in these species. Guinea pigs are prone to stress-related complications and should be handled gently with minimal restraint duration during fluid administration. Chinchillas are extremely sensitive to heat stress and should receive fluid therapy in cool environments. Both species benefit from warming fluids to body temperature and using small-gauge needles to minimize discomfort. These species may vocalize during injection, which is generally normal and does not indicate injury if proper technique is used.

Ferrets represent one of the most common small mammal species receiving long-term subcutaneous fluid therapy, particularly for chronic kidney disease management. The scruff area provides an excellent injection site with loose skin that accommodates fluid pockets well. Most adult ferrets tolerate 30 to 50 milliliters per injection site, though this varies by individual size. Ferrets often become accustomed to regular fluid administration and may tolerate the procedure with minimal restraint once a routine is established. Many ferret owners successfully manage chronic kidney disease with home subcutaneous fluid therapy administered multiple times weekly.

Smaller rodents including hamsters, gerbils, mice, and rats present unique challenges for subcutaneous fluid administration due to their diminutive size. These species have limited subcutaneous space and can only tolerate small fluid volumes, typically measured in milliliters rather than tens of milliliters. The scruff area remains the primary injection site, but volumes must be carefully calculated to avoid overloading the subcutaneous space. Smaller gauge needles, such as 25 to 27 gauge, minimize discomfort in these tiny patients. While subcutaneous fluids can be administered to these species, their small size limits the utility of this route for significant fluid replacement, and alternative routes may be necessary for patients with more substantial hydration deficits.

Subcutaneous fluid administration exists within a spectrum of fluid therapy options available for small mammal patients, with route selection depending on patient condition, clinical urgency, available resources, and treatment goals. Understanding the relationship between subcutaneous fluid administration and alternative approaches helps practitioners and owners appreciate the appropriate role of this technique within comprehensive patient care.

Intravenous fluid administration represents a more direct approach to fluid therapy that provides immediate access to the vascular compartment. Unlike subcutaneous fluids that require gradual absorption, IV fluids enter the bloodstream immediately, allowing rapid correction of fluid deficits and precise control over delivery rates. IV access is essential for emergency resuscitation, management of severe dehydration, and administration of medications that cannot be given subcutaneously. However, IV therapy requires catheter placement and maintenance, is more technically demanding than subcutaneous administration, and typically requires hospitalization. Subcutaneous fluids offer a complementary approach for maintenance needs and mild deficits that do not require the immediacy or precision of IV delivery.

Intraosseous fluid administration provides an emergency alternative when neither IV nor subcutaneous routes are appropriate or achievable. This technique delivers fluids directly into the bone marrow, which functions as a non-collapsible vein even in patients with severe peripheral vasoconstriction. IO access is particularly valuable for emergency resuscitation of small species where IV catheterization may be technically impossible due to vessel size. While IO fluids can achieve rapid delivery rates approaching IV administration, the technique requires specialized equipment and training, carries higher complication risks than subcutaneous injection, and is typically maintained for shorter durations. Subcutaneous fluids cannot substitute for IO access in emergency situations requiring rapid vascular volume expansion.

Oral fluid administration via syringe feeding or stomach tube provides enteral hydration support for patients with functional gastrointestinal tracts. This approach offers the advantage of simultaneous nutritional support alongside fluid delivery, making it valuable for herbivorous small mammals requiring gut motility support. Oral fluids are absorbed more slowly and less predictably than subcutaneous fluids, however, and are contraindicated in patients with GI obstruction, vomiting, or impaired swallowing. Subcutaneous and oral fluid routes are frequently used in combination for comprehensive outpatient management of small mammal patients, with subcutaneous fluids addressing hydration needs while oral administration provides nutritional and GI motility support. The exotic veterinarian determines appropriate combinations of fluid routes based on individual patient needs.